載入...
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
Facing the outbreak of coronavirus disease 2019 (COVID-19) pandemic, there is an urgent need to find protective or curable drugs to prevent or to stop the course of the coronavirus SARS-CoV-2 infection. Recent evidence accumulates that adamantanes, widely used in different neurological diseases, cou...
Na minha lista:
| 發表在: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7190496/ https://ncbi.nlm.nih.gov/pubmed/32388458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102163 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|